Petr F. Hausner, MD, PhD

Education

1966 -1972      M.D., First School of Medicine, Charles University

                        Prague, Czech Republic

1985 - 1988     Ph.D., First School of Medicine, CharlesUniversity

                        Prague, Czech Republic

Post Graduate Education and Training

1972 - 1975     Internship-Residency

                        First Department of Medicine

                        First School of Medicine, Charles University

                        Prague, Czech Republic

                        Program Director: Prof. František Heřmanský, M.D., Dr.Sc.

1975 – 1976    Research Fellowship in Clinical Immunology

                        Laboratory of Immunology

                        First Department of Medicine

                        First School of Medicine, Charles University

                        Prague, Czech Republic

                        Program Director: Associate Prof. Jiří Strejček, M.D., Ph.D.

1981 – 1984    Fellowship in Medical Oncology

                        Department of Oncology

                        First School of Medicine, Charles University

                        Prague, Czech Republic

                        Program Director: Associate Prof. Václav Bek, M.D., Dr.Sc.

1989 – 1994    Visiting Fellow in Molecular Biolog

                        Laboratory of Genetics, Immunogenetic Section

                        National Cancer Institute, National Institutes of Health

                        Bethesda, MD

                        Program Director: Michael Potter, M.D.

                        Mentor: Stuart Rudikoff, Ph.D.

1994 - 1997     Oncology Fellowship, Medical Staff Fellow

                        NIH, National Cancer Institute

                        Division of Clinical Sciences

                        Bethesda, MD

                        Program Director: Robert Wittes, M.D.

Dr. Petr Hausner is a medical oncologist in Baltimore, Maryland and is affiliated with multiple hospitals in the area, including University of Maryland Baltimore Washington Medical Center and University of Maryland Medical Center. He received his medical degree from Karlovy University Faculty of Medicine and has been in practice for more than 20 years.

Internal Medicine, Medical Oncology

Cao Q, Lu M, Heath J, Hausner PF, Alexander HR, Dilsizian V, Chen W. 18-FDG PET/CT in a recurrent diffuse malignant peritoneal mesothelioma.  Clin Nucl Med, 2012 May; 37(5): 492-4.

Hausner, PF. Image-guided Thermal Ablation of Tumor Increases the Plasma Level of Interleukin-6 and Interleukin-10: Is Plasma Level of Interleukin-6 a Surrogate for Immunogenic Cell Death?  J. Vasc. Interv. Radiology, 2013 August 24 (8),  1112-3.

Reese AS, Feigenberg SJ, Husain A, Webb TJ, Hausner PF, Edelman MJ, Feliciano J, Tkaczuk KH, Sharma NK. Stereotactic Ablative Radiotherapy (SABR): Impact on the Immune System and Potential for Future Therapeutic Modulation. Mol Cell Pharmacol. 2013 Jan 1;5(1):19-25.

Lieu CH, Renfro LA, de Gramont A, Meyers JP, Maughan TS, Seymour MT, Saltz L, Goldberg RM, Sargent DJ, Eckhardt SG, Eng C at al.: Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program. J Clin Oncol. 2014 Sep 20;32(27):2975-84.

Hausner, PF, Mishra,M, Hussain: Radiation Recall Pneumonitis Induced by Combined Immune Checkpoint Blockade, JCO Submitted